Evidence map›Paper›PMID 39531344›Full record

ArticleFamily practice2025

Impact of a multifaceted intervention programme on antibiotic prescribing and dispensing in four patient-centred settings in five European countries. The HAPPY PATIENT project.

Ana García-Sangenís, Jesper Lykkegaard, Malene Plejdrup Hansen, Beatriz González López-Valcárcel, Fabiana Raynal, Laura Vallejo-Torres, Lars Bjerrum, Athina Chalkidou, Jette Nygaard Jensen, Ingrid Rebnord and 20 more

Abstract read
In one paragraph

Article in Family practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Ana García-SangenísFundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol, Gran Via de les Corts Catalanes, 587 àtic, 08007, Barcelona, Catalonia, Spain.
Jesper LykkegaardResearch Unit of General Practice, Department of Public Health, University of Southern Denmark, Campusvej 55, DK-5030, Odense, Funen, Denmark.
Malene Plejdrup HansenResearch Unit of General Practice, Department of Public Health, University of Southern Denmark, Campusvej 55, DK-5030, Odense, Funen, Denmark.
Beatriz González López-ValcárcelQuantitative Methods for Economics and Management, University of Las Palmas de Gran Canaria, Juan de Quesada, 30, 35001, Las Palmas de Gran Canaria, Canary Islands, Spain.
Fabiana RaynalQuantitative Methods for Economics and Management, University of Las Palmas de Gran Canaria, Juan de Quesada, 30, 35001, Las Palmas de Gran Canaria, Canary Islands, Spain.
Laura Vallejo-TorresQuantitative Methods for Economics and Management, University of Las Palmas de Gran Canaria, Juan de Quesada, 30, 35001, Las Palmas de Gran Canaria, Canary Islands, Spain.
Lars BjerrumSection of General Practice, Department of Public Health, University of Copenhagen, Øster Farimagsgade, 51014, Copenhagen, Zealand, Denmark.ORCID 0000-0003-0969-0063
Athina ChalkidouSection of General Practice, Department of Public Health, University of Copenhagen, Øster Farimagsgade, 51014, Copenhagen, Zealand, Denmark.
Jette Nygaard JensenDepartment of Clinical Microbiology, Copenhagen University Hospital-Herlev and Gentofte, Gentofte Hospitalsvej, 18A, 2900, Hellerup, Zealand, Denmark.ORCID 0000-0001-5061-9766
Ingrid RebnordNORCE Norwegian Research Centre AS, Nygårtsgaten, 122, 5008, Bergen, Norway.
Bent Håkan LindbergNORCE Norwegian Research Centre AS, Nygårtsgaten, 122, 5008, Bergen, Norway.ORCID 0000-0003-0964-1878
Katja TaxisUnit of Pharmacotherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan, 1, 9700, Groningen, The Netherlands.
Maarten LambertUnit of Pharmacotherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan, 1, 9700, Groningen, The Netherlands.ORCID 0000-0003-4958-9920
Ruta RadzevicieneLtd Mano Seimos Gydytojas (My Family Doctor), Taikos, 119, 94231, Klapéida, Lithuania.
Lina JarusevicieneDepartment of Family Medicine, Lithuanian University of Health Sciences, Eiveniu, 25-0009, Kaunas, Lithuania.
Pia Touboul LundgrenDepartment of Public Health, Nice University Hospital, voie Roman, 30, 06001, Nice, France.
Pascale BrunoDepartment of Public Health, Nice University Hospital, voie Roman, 30, 06001, Nice, France.
Vanessa LesageDepartment of Public Health, Nice University Hospital, voie Roman, 30, 06001, Nice, France.
Anna KowalczykFaculty of Health Sciences, Centre for Family and Community Medicine, Medical University of Lodz, Pl. Generala Józefa Hallera, 19, 0647, Lodz, Poland.
Maciej Godycki-CwirkoFaculty of Health Sciences, Centre for Family and Community Medicine, Medical University of Lodz, Pl. Generala Józefa Hallera, 19, 0647, Lodz, Poland.ORCID 0000-0002-9204-5518
Christos LionisClinic of Social and Family Medicine, School of Medicine, University of Crete, Pros Voutes, 70070003, Heraklion, Crete, Greece.
Maria-Nefeli KarkanaClinic of Social and Family Medicine, School of Medicine, University of Crete, Pros Voutes, 70070003, Heraklion, Crete, Greece.
Marilena AnastasakiClinic of Social and Family Medicine, School of Medicine, University of Crete, Pros Voutes, 70070003, Heraklion, Crete, Greece.
Matilde Bøgelund HansenDepartment of Clinical Microbiology, Copenhagen University Hospital-Herlev and Gentofte, Gentofte Hospitalsvej, 18A, 2900, Hellerup, Zealand, Denmark.
Jonas Kanstrup OlsenResearch Unit of General Practice, Department of Public Health, University of Southern Denmark, Campusvej 55, DK-5030, Odense, Funen, Denmark.
Jens SøndergaardResearch Unit of General Practice, Department of Public Health, University of Southern Denmark, Campusvej 55, DK-5030, Odense, Funen, Denmark.
Daniela ModenaFundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol, Gran Via de les Corts Catalanes, 587 àtic, 08007, Barcelona, Catalonia, Spain.
Stella MallyFundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol, Gran Via de les Corts Catalanes, 587 àtic, 08007, Barcelona, Catalonia, Spain.
Laura ÁlvarezSpanish Society for Family and Community Medicine, Diputació, 320, baixos, 08009, Barcelona, Catalonia, Spain.
Carl LlorCIBER Enfermedades Infecciosas, Instituto de la Salud Carlos III, c. Sinesio Delgado 10, 28029, Madrid, Spain.ORCID 0000-0001-6644-717X

Funding

European Union's Third Health Programme (2014-2020) 900024
6 · The paper itself

Abstract

backgroundThe primary cause of antimicrobial resistance is excessive and non-indicated antibiotic use.

aimTo evaluate the impact of a multifaceted intervention aimed at various healthcare professionals (HCPs) on antibiotic prescribing and dispensing for common infections. DESIGN AND

settingBefore-and-after study set in general practice, out-of-hours services, nursing homes, and community pharmacies in France, Greece, Lithuania, Poland, and Spain.

methodsFollowing the Audit Project Odense method, HCPs from these four settings self-registered encounters with patients related to antibiotic prescribing and dispensing before and after an intervention (February-April 2022 and February-April 2023). Prior to the second registration, the HCPs undertook a multifaceted intervention, which included reviewing and discussing feedback on the first registration's results, enhancing communication skills, and providing communication tools. Indicators to identify potentially unnecessary prescriptions and non-first-line antibiotic choices were developed, and the results of the two registrations were compared.

resultsA total of 345 HCPs registered 10 744 infections in the first registration period and 10 207 infections in the second period. In general practice, participants showed a significant 9.8% reduction in unnecessary antibiotic prescriptions in the second period, whereas limited or no effect was observed in out-of-hours services and nursing homes (0.8% reduction and 4.5% increase, respectively). Pharmacies demonstrated an 18% increase in safety checks, and correct advice in pharmacies rose by 17%.

conclusionExternal factors like COVID-19, antibiotic shortages, and a streptococcal epidemic impacted the intervention's benefits. Despite this, the intervention successfully improved antibiotic use in both settings.

Indexed as

Anti-Bacterial AgentsDrug PrescriptionsInappropriate PrescribingPractice Patterns, Physicians'EuropeFemaleGeneral PracticeHumansMaleNursing HomesPatient-Centered CareAnti-Bacterial Agentsafter-hours careanti-bacterial agentsantimicrobial stewardshipmedical auditnursing homespharmaciesprimary healthcare

Identifiers

PMID39531344
PMCPMC11809241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.